Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

BioVersys

Market Cap: CHF 166.6m

A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.

Werewolf Therapeutics

Market Cap: US$92.4m

A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions.

Genelux

Market Cap: US$157.2m

A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

Rallybio

Market Cap: US$23.6m

A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.

Day One Biopharmaceuticals

Market Cap: US$684.2m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Prime Medicine

Market Cap: US$684.3m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

Cogent Biosciences

Market Cap: US$1.9b

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

CervoMed

Market Cap: US$72.4m

A a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.

REGENXBIO

Market Cap: US$472.8m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Waters

Market Cap: US$17.1b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Tarsus Pharmaceuticals

Market Cap: US$2.3b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

Benitec Biopharma

Market Cap: US$362.3m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Allarity Therapeutics

Market Cap: US$19.7m

A clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs.

Swedish Orphan Biovitrum

Market Cap: SEK 94.7b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Enlivex Therapeutics

Market Cap: US$24.6m

Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.

NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag

Market Cap: Ft35.6b

Manufactures and sells pharmaceutical products in Hungary.

Journey Medical

Market Cap: US$185.7m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Neumora Therapeutics

Market Cap: US$281.8m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

BioAge Labs

Market Cap: US$194.3m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Genetic Analysis

Market Cap: NOK 60.8m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

Bioerg Spólka Akcyjna

Market Cap: zł13.8m

Bioerg Spólka Akcyjna engages in the retail trade of food and chemical products for humans and animals in Poland.

DreamCIS

Market Cap: ₩91.4b

Provides clinical research services in South Korea.

Beijing Konruns PharmaceuticalLtd

Market Cap: CN¥8.4b

Engages in the research and development, production, and sale of pharmaceuticals in China and internationally.

Enwei Pharmaceutical

Market Cap: CN¥3.2b

Develops and sells Chinese medicines in China.

BioGend Therapeutics

Market Cap: NT$5.0b

Researches, develops, and sells orthopedic medical equipment and related products.

KoBioLabs

Market Cap: ₩109.3b

Provides microbiome therapeutics for metabolic, immune, and neurological diseases.

BioLASCO Taiwan

Market Cap: NT$847.8m

Provides bio-materials and surgical services in Taiwan and internationally.

TaiGen Biopharmaceuticals Holdings

Market Cap: NT$6.2b

A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.

Jiangsu Hanbon Science and Technology

Market Cap: CN¥4.0b

Jiangsu Hanbon Science and Technology Co., Ltd.

Aurisco PharmaceuticalLtd

Market Cap: CN¥9.1b

Engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API’s), and formulations catering to the pharmaceutical market worldwide.

Sichuan Goldstone Asia Pharmaceutical

Market Cap: CN¥3.8b

Sichuan Goldstone Asia Pharmaceutical Inc.

Zhejiang Garden BiopharmaceuticalLtd

Market Cap: CN¥7.8b

Zhejiang Garden Biopharmaceutical Co.,Ltd.

Marksans Pharma

Market Cap: ₹74.5b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

Gujarat Terce Laboratories

Market Cap: ₹325.5m

Develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally.

Bafna Pharmaceuticals

Market Cap: ₹4.2b

Manufactures and sells finished pharmaceutical formulations in India.